Pawlak, Alicja Ziolo, Ewa Fiedorowicz, Anna Fidyt, Klaudyna Strzadala, Leon Kalas, Wojciech Additional file 4: Figure S3. of Long-lasting reduction in clonogenic potential of colorectal cancer cells by sequential treatments with 5-azanucleosides and topoisomerase inhibitors Combinatorial treatments increase CRC cell apoptosis. Annexin V-FITC/PI-double staining of HCT116, DLD-1, and HT-29 cells after sequential treatments with 1 μM 5-aza-dC and 25 μM etoposide (n = 3). Figure 1a shows the treatment scheme. Data are presented as means ± SD. *P < 0.05 compared with DNA demethylating agent treatment group and topoisomerase inhibitor treatment group. (PDF 177 kb) 5-azacytidine;Akt;combinatorial therapy;Decitabine;DNA methylation;Doxorubicin;epigenetics;Etoposide;Irinotecan;Mitoxantrone 2016-11-16
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_4_Figure_S3_of_Long-lasting_reduction_in_clonogenic_potential_of_colorectal_cancer_cells_by_sequential_treatments_with_5-azanucleosides_and_topoisomerase_inhibitors/4357148
10.6084/m9.figshare.c.3609257_D1.v1